Tower Research Capital LLC (Trc) Nymox Pharmaceutical Corp Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.19 - $0.49 $260 - $670	1,369 Added 215.25%	2,005 $0
Q1 2023 May 09, 2023	BUY	$0.33 - $0.5 $209 - $318	636 New	636 $0
Q1 2022 May 12, 2022	SELL	$1.21 - $2.0 $10,184 - $16,834	-8,417 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.95 - $2.1 $7,996 - $17,675	8,417 New	8,417 $11,000
Q3 2021 Nov 15, 2021	SELL	$1.3 - $2.23 $22,660 - $38,871	-17,431 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.46 - $2.48 $18,134 - $30,804	12,421 Added 247.92%	17,431 $28,000
Q1 2021 May 17, 2021	SELL	$2.22 - $3.39 $45,738 - $69,844	-20,603 Reduced 80.44%	5,010 $11,000
Q4 2020 Feb 16, 2021	SELL	$1.84 - $2.83 $124,671 - $191,749	-67,756 Reduced 72.57%	25,613 $64,000
Q3 2020 Nov 16, 2020	BUY	$2.3 - $3.66 $188,190 - $299,468	81,822 Added 708.6%	93,369 $230,000
Q2 2020 Aug 13, 2020	BUY	$2.1 - $4.6 $24,248 - $53,116	11,547 New	11,547 $41,000
Q1 2020 May 15, 2020	SELL	$1.69 - $3.88 $19,460 - $44,678	-11,515 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$1.73 - $2.42 $16,495 - $23,074	9,535 Added 481.57%	11,515 $25,000
Q3 2019 Nov 05, 2019	BUY	$1.41 - $2.12 $420 - $631	298 Added 17.72%	1,980 $4,000
Q2 2019 Aug 13, 2019	SELL	$1.33 - $2.12 $5,709 - $9,101	-4,293 Reduced 71.85%	1,682 $2,000
Q1 2019 May 14, 2019	SELL	$1.57 - $2.71 $3,367 - $5,812	-2,145 Reduced 26.42%	5,975 $12,000
Q4 2018 Feb 14, 2019	SELL	$1.31 - $2.53 $1,180 - $2,279	-901 Reduced 9.99%	8,120 $11,000
Q3 2018 Nov 13, 2018	BUY	$2.46 - $3.7 $22,191 - $33,377	9,021 New	9,021 $22,000
Q1 2018 May 15, 2018	SELL	$3.09 - $4.43 $5,719 - $8,199	-1,851 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$3.29 - $4.06 $463 - $572	141 Added 8.25%	1,851 $6,000
Q3 2017 Nov 14, 2017	BUY	$3.36 - $4.02 $5,745 - $6,874	1,710	1,710 $7,000

Others Institutions Holding NYMX

# of Institutions

Shares Held

150K

Call Options Held

Put Options Held

View Full List

About NYMOX PHARMACEUTICAL CORP

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

More about NYMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account